Skip to main content
. 2022 Feb 18;77:100016. doi: 10.1016/j.clinsp.2022.100016

Fig. 1.

Fig 1

Univariate analysis of the seroprevalence of anti-SARS-CoV-2 antibodies in the three periods evaluated and according to the blood donation sites. The seroprevalence for the whole group and according to the blood donation sites increased over time, and comparisons by qui-square test showed statistical significance (p < 0.001).